Skip to main content
Back to News
Simile secured 100 million dollars in Series A funding led by Index Ventures to develop AI agents th...
Funding
1 min read
US

Simile secured 100 million dollars in Series A funding led by Index Ventures to develop AI agents th...

The AMW Read

This is an incremental update on a new player (Simile) in the AI agents segment; it does not trigger cross.Β§D because the $100M round is below the $500M threshold.
NoveltySignificance
AI Agents Β· Player Map

Simile secured 100 million dollars in Series A funding led by Index Ventures to develop AI agents that simulate human behavior. Training on interviews and behavioral science, the platform enables firms like CVS to replace focus groups with high-fidelity digital twins. This technology allows for the rapid testing of product launches and strategy in simulated environments. We are seeing a systemic shift where synthetic populations become the primary tool for de-risking commercial operations. πŸš€

#AI #VentureCapital #BehavioralScience #Simile #RetailInnovation

How This Connects

Based on AI Agents Β· Player Map

  1. 3w agoUniPat AI releases SaaS-Bench, Claude Opus 4.7 passes only 3.8% of 106 real-office tasks, breaking the illusion of full office automation.
  2. 1mo agoAnthropic is shifting focus to compete with OpenAI and Microsoft over the agent control plane, the o...Anthropic
  3. 1mo agoAdobe launches Adobe CX Enterprise, an agentic AI system for customer experienceAdobe
  4. 1mo agoAnthropic Launches 10 Financial Services Agents, Sending FactSet Shares Down 8%Anthropic
  5. 1mo agoAlibaba's Metis agent slashes redundant AI tool calls from 98% to 2%, boosting accuracyAlibaba
  6. 4mo agoSimile secured 100 million dollars in Series A funding led by Index Ventures to develop AI agents th... Β· THIS ARTICLE

Related News

More news from Simile

Stay updated with the latest news and announcements from Simile.

View all Simile news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard